Punam Malik

Hematology | Oncology

3333 Burnet Ave # 7015
Cincinnati, OH 45229

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell Disease.

Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell Disease.

Journal: Blood

Published: February 20, 2026

Renin-angiotensin-aldosterone system inhibition exacerbates anemia in sickle cell disease.

Renin-angiotensin-aldosterone system inhibition exacerbates anemia in sickle cell disease.

Journal: Blood

Published: February 20, 2026

Cure Sickle Cell Initiative recommendations on common data elements for sickle cell disease gene therapy trials.

Cure Sickle Cell Initiative recommendations on common data elements for sickle cell disease gene therapy trials.

Journal: Blood advances

Published: December 16, 2025

Cure Sickle Cell Initiative Recommendations on Common Data Elements for Sickle Cell Disease Gene Therapy Trials.

Cure Sickle Cell Initiative Recommendations on Common Data Elements for Sickle Cell Disease Gene Therapy Trials.

Journal: Blood advances

Published: December 16, 2025

Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview.

Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview.

Journal: American journal of hematology

Published: December 12, 2025

Longitudinal changes and predictors of cardiac extracellular volume fraction in sickle cell anemia.

Longitudinal changes and predictors of cardiac extracellular volume fraction in sickle cell anemia.

Journal: Blood. Red cells & iron

Published: November 28, 2025

Angiotensin signaling is essential for stress erythropoiesis but causes retention of dysfunctional mitochondria in RBCs.

Angiotensin signaling is essential for stress erythropoiesis but causes retention of dysfunctional mitochondria in RBCs.

Journal: JCI insight

Published: September 26, 2025

An engineered β-globin homology donor reveals insights into β-globin expression and betters HDR.

An engineered β-globin homology donor reveals insights into β-globin expression and betters HDR.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 01, 2025

A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea.

A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea.

Journal: Blood

Published: December 20, 2024

Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial.

Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial.

Journal: Nature medicine

Published: August 23, 2024

Preclinical efficacy of a modified gamma-globin lentivirus gene therapy in Berkeley sickle cell anemia mice and human xenograft models.

Preclinical efficacy of a modified gamma-globin lentivirus gene therapy in Berkeley sickle cell anemia mice and human xenograft models.

Journal: Molecular therapy. Methods & clinical development

Published: July 24, 2024

Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies.

Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies.

Journal: PloS one

Published: April 24, 2024

Showing 1-12 of 90

Last Updated: 09/26/2026